The congress will carry on from the successful recent congress held in Mannheim, Germany and will offer in-person and virtual attendance.

The meeting will explore the latest developments in basic, translational and clinical research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment.

One of the key features of the Congress is the high-level interdisciplinary exchange between clinicians and basic researchers. With many world-leading experts already confirmed, the EAS 2024 scientific program will offer an overview of the latest current research in the field – including the award-winning Anitschkow Lecture, outstanding Keynote Lectures, state-of-the-art Plenary Sessions, and focused Workshops and Advance Clinical Seminars.